Cynthia L. Schwalm's Insider Trades & SAST Disclosures

Cynthia L. Schwalm's most recent trade in G1 Therapeutics Inc was a trade of 19,620 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2021.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
G1 Therapeutics Inc
Cynthia L. Schwalm Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 19,620 19,620 - - Stock Options (Right to Buy)
G1 Therapeutics Inc
Cynthia L. Schwalm Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 4,389 5,889 (0%) 0% 0 Common Stock
Lisata Therapeutics Inc
Cynthia L. Schwalm Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jan 2021 37,735 80,417 (0%) 0% 0 Common Stock
G1 Therapeutics Inc
Cynthia L. Schwalm Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2020 20,000 20,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades